胶质瘤自杀基因治疗进展
摘要
应用基因载体可以将某些目的基因 (具有转化功能 )导入胶质瘤细胞 ,这些高效目的基因能将体内无毒或低毒的“前药”在胶质瘤局部转化为一种局部浓度高、对胶质瘤毒性作用强而全身毒副作用小的化疗药。旁观者效应则可通过增加胶质瘤细胞缝隙连接而自动放大局部化疗药的治疗效果 ,已发现cAMP可大大加强旁观者效应。削弱血
出处
《国外医学（神经病学．神经外科学分册）》
2001年第4期278-281,共4页
Foreign Medical Sciences（Section On Neurology & Neurosurgery）
参考文献14
-
1Kokoris MS, Sabo P, Adman ET, et al. Enhancement of tumor ablation by a selected HSV- 1 thymidine kinase mutant. Gene Ther, 1999,6 (8): 1415 - 1426
-
2Rainov NG, Dobberstein KU, Sena- Esteves M ,et al. New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2 -aminoanthracene/4- ipomeanol. Hum Gen Ther, 1998,9(9): 1261 -1273
-
3Galipeau J ,LiH, PaquinA, et al. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in exprimental brain cancer. Cancer Res, 1999 , 59(10):2384-2394
-
4Dupont F, Avalosse B, Karim A, et al. Tums-selective gene transduction and cell killing with an oncotropic autonomous parvovirus - based vector. Gene Ther, 2000,7(9):790-796
-
5Robe PA, Princen F, Martin D, et al. Pharmcological modulation of the bystander effect in the herpes simplwz virus thymidine kinase/ganciclovir gene therapy system: effects of dibutyryl adenosine 3' ,5' - cyclic monophoshate, alpha- glycyrrhetinic acid, and cytosine arabinoside.Biochem Pharmacol ,2000 , 60(2) :241 - 249
-
6Shinoura N ,Chen L, WaniMA, et al. Protein and messenger RNA expression of connexin43 in astrocytomas: implications in brain tumor gene therapy. J Neurosurg, 1996, 84(5):839-845; discussion 846
-
7LeMay DR, Kittaka M, G ordon EM, et al. Intravenous RMP- 7 increases delivery of ganciclovir into rat brain tumors and enhanced the effects of herpes simplex virus thyymidine kinase gene therapy. Hum Gene Ther, 1998, 9(7) :989 - 995
-
8Pizzato M,Franchin E, Calvi P, et al. Production and characterization of bicistronic Moloney - based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer. Gene Ther, 1998, 5(7):1003-1007
-
9Benedetti S, Dimeco F, Pollo B,et al. Limited efficacy of the HSVTK/GCV system for gene therapy of malignant glioma and perspectives for the combined transduction of the interleukin - 4 gene. Hum Gene Ther, 1997, 8(11):1345- 1353
-
10Okada H, Giezeman-Smits KM, Tahara H, et,al. Effective cytokine gene therapy against an intracranial glioma using a retrovially transduced IL-4 plus HSVtk tumor vaccine. Gene Ther, 1999,6(2):219-226
-
1龚建忠.非小细胞肺癌脑转移的化疗进展[J].医药前沿,2015,5(26):8-11. 被引量：1
-
2谢娟,秦玲,张玉蓉,茅志娟.妇科恶性肿瘤根治术78例行髂内动脉灌注化疗的护理[J].南通大学学报（医学版）,2007,27(4):324-324. 被引量：2
-
3张少云,赵晴,张素英.脐血T淋巴细胞转化功能的研究[J].白血病,2000,9(1):41-41. 被引量：5
-
4吴国彦,宋永玲,郑凯平,蔡唯佳.原发性恶性脑瘤患者血淋巴细胞转化功能与微核改变的相关性[J].肿瘤,1992,12(3):126-127.
-
5陈伟,董胜国.垂体肿瘤转化基因与肿瘤[J].国外医学（肿瘤学分册）,2004,31(3):179-182. 被引量：1
-
6吴国彦,宋永玲.颅内肿瘤患者血淋巴细胞转化功能改变及其临床意义[J].汕头科技,1989(1):33-35.
-
7邹君杰,冯耀良,戴存才.化疗药物对胰腺癌细胞株Aspc-1和Bxpc-3生长抑制作用的研究[J].介入放射学杂志,2004,13(2):171-173.
-
8程石.得力生联合化疗药物对胰腺癌细胞株JF305生长的抑制作用[J].现代肿瘤医学,2006,14(9):1054-1056.
-
9邹君杰,冯耀良,戴存才.常用化疗药物对胰腺癌细胞株Aspc-1和Bxpc-3生长抑制作用的研究[J].南京医科大学学报（自然科学版）,2004,24(1):34-37.
-
10王启远,徐岩,许贤姬,高云飞,周长江.c-myc和hPTTG1在结直肠癌表达的研究进展[J].国际消化病杂志,2009,29(6):418-419.
